Brookings Schaeffer on Health Policy
More from Brookings Schaeffer on Health Policy Blog
-
Value-Based Pricing For Pharmaceuticals In The Trump Administration
The change in administration is an opportune moment for CMS to assume a leadership role with respect to value-based pricing.Â
Categorized in -
The Essential Scan: Top Findings in Health Policy Research | Edition 15
What’s the latest in health policy research? The Essential Scan, produced by the Schaeffer Initiative for Innovation in Health Policy, aims to help keep you informed on the latest research and what it means for policymakers.
-
To Promote Stability in Health Insurance Exchanges, End the Uncertainty Around Cost-Sharing and Other Rules
While it is unclear whether the changes included in the CMS rule will have a small positive or negative impact on market stability, it is clear that the impact pales in comparison to the instability caused by the lack of commitment to fund the ACA’s cost-sharing reduction subsidies or to enforce the individual mandate.
Categorized in -
How Should The Trump Administration Handle Medicare’s New Bundled Payment Programs?
There is room to modify the bundled payment models to address concerns raised by Secretary Price and others without damaging the integrity of the models.
-
The Essential Scan: Top Findings in Health Policy Research | Edition 14
What’s the latest in health policy research? The Essential Scan, produced by the Schaeffer Initiative for Innovation in Health Policy, aims to help keep you informed on the latest research and what it means for policymakers.
-
Viewpoint – Making Health Care Markets Work: Competition Policy for Health Care
The authors propose a new competition policy for health care that involves multiple federal agencies in addition to the antitrust enforcement agencies, state governments, and private stakeholders.
Categorized in -
New Changes to Essential Benefits in the GOP Health Bill Could Jeopardize Protections Against Catastrophic Costs, Even for People with Job-Based Coverage
Weakening essential health benefit standards could also have important negative consequences for the coverage offered by employers of all sizes because it would weaken the ACA’s guarantee of protection against catastrophic costs.
Categorized in -
Tackling the Opioid Crisis with Compassion, New Ways to Reduce Use and Treatment
This piece explains how we arrived at the current opioid crisis, policies that have been tried thus far, and options to address the crisis moving forward.
Categorized in -
How will the House GOP Health Care Bill Affect Individual Market Premiums?
Schaeffer Initiative experts estimate that premiums would be around 13% higher under the AHCA than they are under current law, holding plan generosity and the individual market age distribution fixed at their current law levels.
Categorized in -
Improving Hospital Incentives with Better Cost Data
The method currently used by the Centers for Medicare and Medicaid Services to set Medicare payment rates is fairly crude. CMS could draw on cost data that are produced by hospitals’ internal systems to increase the efficiency of the health care system.
Categorized in